This study is a prospective study aimed to develop and validate the performance of combined multi-omitcs assays for early detection of gynecologic cancers. Biomarkers of cfDNA methylation, ctDNA mutation and blood miRNA markers will be evaluated. The study will enroll approximately 495 female participants, including participants with gynecologic cancers or benign diseases.
Study Type
OBSERVATIONAL
Enrollment
495
Blood collection and multi-cancer early detection testing
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Sensitivity,specificity and tissue of origin accuracy of the multi-omics model as early detection for gynecologic cancers.
Time frame: 12 months
Sensitivity and specificity of the multi-omics model in early detection of gynecologic cancers in different stages.
Time frame: 12 months
Sensitivity and specificity of the multi-omics model in early detection of different gynecologic cancer diseases
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.